Skip to main content
    V

    Vericel Corp Ord (VCEL)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $57.48
    +0.52 (+0.91%)

    Market Cap: $2.91B

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Vericel Corp Ord (VCEL) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Vericel Corp Ord are Vera Therapeutics (VERA), Viridian Therapeutics (VRDN) and Vir Biotechnology (VIR). By market cap, Vericel Corp Ord ranks 7th of the 13 companies on this page; Viking Therapeutics (VKTX) is the largest at $3.73B.

    Peer Comparison

    VCEL's revenue growth of 26.5% is above the peer median of 0.0%. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Vericel Corp Ord (VCEL)$2.91B89.8x9.1x10.3%N/A26.5%0.00%
    Vera Therapeutics Inc (VERA)$2.03BN/A189.3x0.0%-83.0%0.0%0.00%
    Viridian Therapeutics Inc (VRDN)$3.51BN/A128.5x0.0%-41.8%-63.5%0.00%
    Vir Biotechnology Inc (VIR)$1.71BN/A5.4x-61.0%N/A19582.0%0.00%
    Legend Biotech Corp (LEGN)$3.39B266.5x2.3x-0.0%N/A32.0%0.00%
    Xencor Inc (XNCR)$2.78BN/A13.5x-58.8%-17.3%454.9%0.00%
    Celcuity LLC (CELC)$3.15BN/AN/A0.0%-25.2%0.0%0.00%
    Pharvaris BV (PHVS)$2.36BN/AN/A0.0%N/A0.0%0.00%
    Celldex Therapeutics Inc (CLDX)$2.26BN/AN/A0.0%N/A-97.0%0.00%
    Beam Therapeutics Inc (BEAM)$2.36BN/A15.0x-73.9%-29.7%-96.8%0.00%
    Iovance Biotherapeutics Inc (IOVA)$3.59BN/A9.1x-58.2%N/A80.1%0.00%
    Viking Therapeutics Inc (VKTX)$3.73BN/AN/A0.0%-61.0%0.0%0.00%
    Enliven Therapeutics Inc. (ELVN)$3.59BN/AN/A0.0%N/A0.0%0.00%
    Peer median$2.97B266.5x13.5x0.0%-35.7%0.0%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Vericel Corp Ord, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.

    CompanyAboutPeers
    Vera Therapeutics Inc (VERA)
    Vera Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immune diseases...
    VERA competitors
    Viridian Therapeutics Inc (VRDN)
    Viridian Therapeutics, Inc., a biotechnology company, develops treatments for patients with serious illnesses.
    VRDN competitors
    Vir Biotechnology Inc (VIR)
    Vir Biotechnology, Inc., a clinical-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases.
    VIR competitors
    Legend Biotech Corp (LEGN)
    Legend Biotech Corporation, a clinical-stage biopharmaceutical company, is dedicated to the discovery and development of new cell therapies for oncology...
    LEGN competitors
    Xencor Inc (XNCR)
    Xencor, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of cytokine and monoclonal antibody therapies designed...
    XNCR competitors
    Celcuity LLC (CELC)
    Celcuity Inc., a clinical-stage biotechnology company, discovers cancer subtypes and therapeutic options for cancer patients in the United States.
    CELC competitors
    Pharvaris BV (PHVS)
    Pharvaris NV, a clinical-stage biopharmaceutical company, focuses on the development and commercialization of rare disease therapies.
    PHVS competitors
    Celldex Therapeutics Inc (CLDX)
    Celldex Therapeutics, Inc., a biopharmaceutical company, is dedicated to the development of therapeutic monoclonal and bispecific antibodies for the treatment...
    CLDX competitors
    Beam Therapeutics Inc (BEAM)
    Beam Therapeutics Inc., a biotechnology company, develops precision genetic drugs for patients with serious illnesses in the United States.
    BEAM competitors
    Iovance Biotherapeutics Inc (IOVA)
    Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness...
    IOVA competitors
    Viking Therapeutics Inc (VKTX)
    Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, is focused on developing new therapies for metabolic and endocrine disorders.
    VKTX competitors
    Enliven Therapeutics Inc. (ELVN)
    Enliven Therapeutics Inc. (Ticker: ELVN) is an innovative biotechnology company focused on transforming cancer therapies and addressing critical healthcare...
    ELVN competitors

    Frequently Asked Questions About VCEL

    Who are Vericel Corp Ord's main competitors?

    The companies most similar to Vericel Corp Ord include Vera Therapeutics (VERA), Viridian Therapeutics (VRDN), Vir Biotechnology (VIR), Legend Biotech (LEGN) and Xencor (XNCR), listed from the closest match.

    Who is Vericel Corp Ord's biggest competitor?

    Viking Therapeutics (VKTX) is the largest of the similar companies at $3.73B; Vera Therapeutics (VERA) is the closest match by business profile, size, sector and industry.

    How does VCEL stock compare with its competitors?

    VCEL's P/E is 89.8x against a peer median of 266.5x; its P/S is 9.1x against a peer median of 13.5x; its net margin is 10.3% against a peer median of 0.0%.

    Which of Vericel Corp Ord's competitors pays a higher dividend?

    Vericel Corp Ord pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.

    Is Vericel Corp Ord bigger than its competitors?

    No. Vericel Corp Ord is 7th by market cap among the 13 companies on this page; the largest is Viking Therapeutics (VKTX) at $3.73B.